Gloria F.
- Country
- Germany
- Department
- Clinic and Polyclinic for Thoracic, Cardiac, and Thoracic Vascular Surgery
Research Overview
Data & Insights
Has run more than one trial at 0 of 15 partner sites.
Specializations
Thoracic Oncology
Investigator Gloria Färber concentrates on malignant diseases of the chest cavity, especially tumors of the lung and mediastinum.
- Non‑Small Cell Lung Cancer
- Small Cell Lung Cancer
- Thoracic Sarcoma
- Mesothelioma
- Advanced‑Stage Solid Tumors
Clinical focus includes evaluation of novel systemic and local therapies for these thoracic malignancies.
Cardiac Amyloidosis and Cardiomyopathy
Research activities target infiltrative cardiac disorders that impair myocardial function.
- Transthyretin Amyloid Cardiomyopathy
- AL Amyloidosis with Cardiac Involvement
- Hypertrophic Cardiomyopathy
- Heart Failure with Preserved Ejection Fraction
- Cardiac Structural Disease
Efforts aim to improve diagnostic precision and therapeutic outcomes for patients with cardiac protein deposition diseases.
Hematologic Malignancies and Stem Cell Transplantation
The investigator’s portfolio includes aggressive blood cancers and their curative transplant approaches.
- Acute Myeloid Leukemia
- Acute Lymphoblastic Leukemia
- Multiple Myeloma
- Chronic Lymphocytic Leukemia
- Graft‑Versus‑Host Disease
Work emphasizes conditioning regimens, immune reconstitution, and post‑transplant complication management.
Thoracic Vascular Surgery and Pulmonary Vascular Disease
Clinical investigations address surgical and endovascular therapies for diseases of the thoracic aorta and pulmonary circulation.
- Thoracic Aortic Aneurysm
- Thoracic Aortic Dissection
- Pulmonary Embolism
- Pulmonary Hypertension
- Vascular Reconstruction
Studies evaluate peri‑operative risk reduction and long‑term vessel patency.
Immunotherapy and Cellular Therapies
Investigator Färber participates in trials exploring immune‑based strategies for cancer treatment.
- CAR‑T Cell Therapy
- Checkpoint Inhibitors
- Bispecific Antibodies
- Immune‑Related Adverse Events
- Combination Immuno‑Oncology Regimens
Focus is on safety profiling and efficacy enhancement of these novel immunologic approaches.
Related Investigators
Researchers in similar fields or departments
Want to know more about this investigator?
We can share extended profile information and contact details.
Is something out of date?
Tell us what needs correcting and we'll update this profile.